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Using creative co-production to develop a treatment decision support tool for people 
with malignant pleural effusion  
Grindell C, Bec R, Tod AM, Bhatnagar R, Sivakumar P, Evison M, Morley A, Ahmed M,  
Ahmed L, Wolstenholme D. 
 
Background 
Malignant pleural effusion (MPE) is a common, serious problem predominantly seen in 
metastatic lung and breast cancer and malignant pleural mesothelioma (MPM). Recurrence 
of MPE is common, and symptoms significantly impact on SHRSOH¶V daily lives. 
 
No ideal treatment strategy for MPE currently exists. However, there are four main treatment 
options aimed at relieving symptoms and improving quality of life. These include aspiration, 
thoracoscopy with pleurodesis, bedside pleurodesis and indwelling pleural catheter  
Choosing which option is best depends on many factors and making decisions can be 
challenging in pressured clinical environments. This project aimed to develop a support tool 
to help this decision making process for people with MPE. 
 
Methods 
Pleural teams from three sites in the UK undertook a creative co-production (CC-P) 
approach led by the translating knowledge into action (TK2A) team of the NIHR Research 
Collaboration and Leadership in Applied Health Research and Care Yorkshire and Humber.  
 
The geographical distance between the three sites and the ill-health of service users meant 
a novel distributed model of CC-P was used. This comprised of three locally run workshops 
with clinicians, patients and carers that were designed and structured by the TK2A CC-P 
experts. This was followed by a joint national workshop with representatives from all 
stakeholder groups to consider findings and outputs from local meetings.  
 
The design team worked with participants to develop outputs including patient timelines and 
personas. These were used as the basis to develop and test visible and tangible prototype 
ideas.  
 
Results 
Some key messages emerged that informed prototype development. Understanding and 
managing their pleural effusion was the priority for patients, not their overall cancer journey. 
Preferred methods for receiving information were varied but visual and graphic approaches 
were favoured.  The main influences on SHRSOH¶V decisions about their MPE treatment were 
personal aspects of their lives (e.g. how active they are, what support they have at home). 
 
The design team developed a first prototype (i.e. a video representing a web-based support 
tool) to help people identify personal priorities and guide shared treatment decisions. This 
requires further development before implementation into practice. 
 
Conclusion 
The creative design methods and distributed model of co-production used in this project 
overcame many of the barriers to traditional co-production methods such as power, 
language and time. They allowed specialist pleural teams and service users to work together 
to create a patient-facing decision support tool owned by those who will use it. 
 
 
 
 
 
